CUSIP 746964105COMQTTBQ4 2025
15 filings · latest Mar 12, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Orbimed Advisors LLC | 2.25M | $7.48M |
| 2 | Atlas Venture Life Science Advisors, LLC | 2.09M | $6.95M |
| 3 | Carlyle Group Inc. | 1.10M | $3.62M |
| 4 | Acorn Capital Advisors, LLC | 493.4K | $1.64M |
| 5 | Vanguard Group Inc | 321.1K | $1.07M |
| 6 | Arch Venture Management, LLC | 320.5K | $1.06M |
| 7 | Pfizer Inc | 277.8K | $922.2K |
| 8 | Sanofi | 244.1K | $810.4K |
| 9 |
| 4 | Feb 13, 2026 | Pfizer Inc. (Irs Identification No.: 13-5315170) | 13G/A | 11.0% | 277.8K | SEC |
| 5 | Apr 8, 2025 | Sio Capital Management, LLC | 13G | — | — | SEC |
| 6 | Feb 14, 2025 | Bristol Myers Squibb Co | 13G/A | 11.0% | 200.2K | SEC |
| 7 | Feb 10, 2025 | Sio Capital Management, LLC | 13G | 5.7% | 697.4K | SEC |
| 8 | Nov 14, 2024 | 5am Ventures IV, L.P. | 13G/A | — | — | SEC |
| 9 | Nov 13, 2024 | Bristol Myers Squibb Co | 13G | 6.2% | 759.1K | SEC |
| 10 | Oct 25, 2024 | Temasek Holdings (Private) Ltd | 13G/A | 2.6% | 313.9K | SEC |
See the full Schedule 13D/13G history for Q32 Bio Inc.
Unlock full history| 213.4K |
| $708.4K |
| 10 | Geode Capital Management, LLC | 106.1K | $352.4K |